pd 128907 has been researched along with bp 897 in 1 studies
| Studies (pd 128907) | Trials (pd 128907) | Recent Studies (post-2010) (pd 128907) | Studies (bp 897) | Trials (bp 897) | Recent Studies (post-2010) (bp 897) |
|---|---|---|---|---|---|
| 16 | 0 | 9 | 79 | 0 | 15 |
| Protein | Taxonomy | pd 128907 (IC50) | bp 897 (IC50) |
|---|---|---|---|
| D(3) dopamine receptor | Homo sapiens (human) | 0.0203 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, X; Huang, M; Ji, M; Wang, Y | 1 |
1 other study(ies) available for pd 128907 and bp 897
| Article | Year |
|---|---|
Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents.
Topics: Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Design; Ligands; Mice; Molecular Structure; Morpholines; Naloxone; Receptors, Dopamine D3; Structure-Activity Relationship; Substance Withdrawal Syndrome | 2021 |